Cover Image

Economic burden of SARS-CoV-2 patients with multi-morbidity: A systematic review protocol

Economic burden issues in SARS-CoV-2 patients with underlying co-morbidities are enormous resources for patient treatment and management. The uncertainty costs for clinical management render the healthcare system catatonic and incurs deficits in national annual budgets. This article focuses on syste...

Full description

Saved in:
Bibliographic Details
Main Authors: Azzeri, Amirah, Ramlee, Mohd, Noor, Mohd, Jaafar, Mohd, Rochmah, Thinni, Dahlui, Maznah
Format: Article
Published: MDPI 2022
Subjects:
R Medicine
RA Public aspects of medicine
Online Access:http://eprints.um.edu.my/40836/
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.um.eprints.40836
record_format eprints
spelling my.um.eprints.408362023-09-27T01:41:55Z http://eprints.um.edu.my/40836/ Economic burden of SARS-CoV-2 patients with multi-morbidity: A systematic review protocol Azzeri, Amirah Ramlee, Mohd Noor, Mohd Jaafar, Mohd Rochmah, Thinni Dahlui, Maznah R Medicine RA Public aspects of medicine Economic burden issues in SARS-CoV-2 patients with underlying co-morbidities are enormous resources for patient treatment and management. The uncertainty costs for clinical management render the healthcare system catatonic and incurs deficits in national annual budgets. This article focuses on systematic steps towards selecting and evaluating literature to uncover gaps and ways to help healthcare stakeholders optimize resources in treating and managing COVID-19 patients with multi-morbidity. A systematic review of all COVID-19 treatment procedures with co-morbidities or multi-morbidity for the period from 2019 to 2022 was conducted. The search includes studies describing treatment costs associated with multi- or co-morbidity cases for infected patients and, if concurrently reported, determining recurring expenses. Study selection will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Galbraith plots and I-2 statistics will be deployed to assess heterogeneity and to identify potential sources. A backward elimination process will be applied in the regression modelling procedure. Based on the number of studies retrieved and their sample size, the subgroup analysis will be stratified on participant disease category, associated total costs, and degree of freedom in cost estimation. These studies were registered in the PROSPERO registry (ID: CRD42022323071). MDPI 2022-10 Article PeerReviewed Azzeri, Amirah and Ramlee, Mohd and Noor, Mohd and Jaafar, Mohd and Rochmah, Thinni and Dahlui, Maznah (2022) Economic burden of SARS-CoV-2 patients with multi-morbidity: A systematic review protocol. International Journal of Environmental Research and Public Health, 19 (20). ISSN 1660-4601, DOI https://doi.org/10.3390/ijerph192013157 <https://doi.org/10.3390/ijerph192013157>. 10.3390/ijerph192013157
institution Universiti Malaya
building UM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Malaya
content_source UM Research Repository
url_provider http://eprints.um.edu.my/
topic R Medicine
RA Public aspects of medicine
spellingShingle R Medicine
RA Public aspects of medicine
Azzeri, Amirah
Ramlee, Mohd
Noor, Mohd
Jaafar, Mohd
Rochmah, Thinni
Dahlui, Maznah
Economic burden of SARS-CoV-2 patients with multi-morbidity: A systematic review protocol
description Economic burden issues in SARS-CoV-2 patients with underlying co-morbidities are enormous resources for patient treatment and management. The uncertainty costs for clinical management render the healthcare system catatonic and incurs deficits in national annual budgets. This article focuses on systematic steps towards selecting and evaluating literature to uncover gaps and ways to help healthcare stakeholders optimize resources in treating and managing COVID-19 patients with multi-morbidity. A systematic review of all COVID-19 treatment procedures with co-morbidities or multi-morbidity for the period from 2019 to 2022 was conducted. The search includes studies describing treatment costs associated with multi- or co-morbidity cases for infected patients and, if concurrently reported, determining recurring expenses. Study selection will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Galbraith plots and I-2 statistics will be deployed to assess heterogeneity and to identify potential sources. A backward elimination process will be applied in the regression modelling procedure. Based on the number of studies retrieved and their sample size, the subgroup analysis will be stratified on participant disease category, associated total costs, and degree of freedom in cost estimation. These studies were registered in the PROSPERO registry (ID: CRD42022323071).
format Article
author Azzeri, Amirah
Ramlee, Mohd
Noor, Mohd
Jaafar, Mohd
Rochmah, Thinni
Dahlui, Maznah
author_facet Azzeri, Amirah
Ramlee, Mohd
Noor, Mohd
Jaafar, Mohd
Rochmah, Thinni
Dahlui, Maznah
author_sort Azzeri, Amirah
title Economic burden of SARS-CoV-2 patients with multi-morbidity: A systematic review protocol
title_short Economic burden of SARS-CoV-2 patients with multi-morbidity: A systematic review protocol
title_full Economic burden of SARS-CoV-2 patients with multi-morbidity: A systematic review protocol
title_fullStr Economic burden of SARS-CoV-2 patients with multi-morbidity: A systematic review protocol
title_full_unstemmed Economic burden of SARS-CoV-2 patients with multi-morbidity: A systematic review protocol
title_sort economic burden of sars-cov-2 patients with multi-morbidity: a systematic review protocol
publisher MDPI
publishDate 2022
url http://eprints.um.edu.my/40836/
_version_ 1781704531782926336
score 13.211869

Similar Items